Skip to main content
. Author manuscript; available in PMC: 2008 Apr 1.
Published in final edited form as: J Neuroimmunol. 2007 Feb 27;185(1-2):168–174. doi: 10.1016/j.jneuroim.2007.01.011

Table 1.

Combined Unique (CU) MRI Lesions for Responders and Non-Responders to Interferon Therapy at Baseline (-1) through 24 weeks

Patient IFN-β -1 4 8 12 16 20 24 mean CU lesions on IFN total CU lesions on IFN
2 qw 0 1 0 0 0 1 0 0.33 2
12 qw 4 1 0 0 0 0 0 0.17 1
17 qw 0 1 1 0 0 0 1 0.5 3
19 qw 0 0 0 1 0 1 1 0.5 3
1 tiw 0 1 0 0 0 0 0 0.17 1
4 tiw 1 0 0 0 0 0 0 0 0
6 tiw 3 0 0 0 0 0 1 0.17 1
8 tiw 0 0 0 0 0 0 0 0 0
10 tiw 1 0 0 0 0 0 0 0 0
15 tiw 0 0 1 0 0 0 1 0.33 2
5 qw 4 1 7 4 2 6 20 6.67 40
9 qw 3 9 7 3 4 6 6 5.83 35
13 qw 0 0 0 3 4 0 8 2.5 15
18 qw 1 0 1 4 4 3 3 2.5 15
14 tiw 18 2 3 0 8 2 14 4.83 29